BRIEF published on 10/02/2024 at 07:05, 1 month 19 days ago Cureus GmbH Marks Four Years with Continued Expansion Expansion Property Development Cureus GmbH Care Homes PECURIA
PRESS RELEASE published on 10/02/2024 at 07:00, 1 month 19 days ago Cureus continues to expand and looks back on four successful years of existence to date Cureus expands with new care home projects, sales via PECURIA, and strong growth. IZ Research ranks Cureus as top development firm in Germany. Carestone sells locations individually Expansion Development Cureus PECURIA Care Home
BRIEF published on 07/08/2024 at 07:05, 4 months 13 days ago Cureus Grows and Expands Its Value Chain Real Estate Sustainability Property Development Care Homes
PRESS RELEASE published on 07/08/2024 at 07:00, 4 months 13 days ago Cureus grows and expands its value chain Cureus expands its value chain by starting construction of 248 care units in Q2/24, completing 272 care units, and acquiring a stake in PECURIA. Sustainability report 2023 published Construction Sustainability Report Cureus Value Chain Expansion PECURIA
BRIEF published on 04/09/2024 at 07:05, 7 months 12 days ago Cureus GmbH Reports Strong Start in 2024 with Significant Real Estate Developments Real Estate Sustainability Company Growth Care Home Development Award Recognition
PRESS RELEASE published on 04/09/2024 at 07:00, 7 months 12 days ago Cureus sees successful start to 2024 Cureus GmbH, a leading property developer specializing in care home portfolio, reports successful Q1 2024 with completed and ongoing projects. Recognized for sustainability and employer quality Sustainability Property Developer Q1 2024 Cureus GmbH Care Home Portfolio
PRESS RELEASE published on 10/09/2023 at 07:00, 1 year 1 month ago Cureus in Q3 2023: eight projects with 671 units completed, three properties sold, land acquisition continues
PRESS RELEASE published on 07/05/2023 at 07:00, 1 year 4 months ago Cureus continues to hold its own in project development in the second quarter of 2023
PRESS RELEASE published on 06/30/2023 at 07:00, 1 year 4 months ago Cureus publishes Sustainability Report 2022
PRESS RELEASE published on 05/12/2023 at 07:00, 1 year 6 months ago Cureus survey: Municipal decision-makers expect a clear increase in the number of care places needed, but see solution in assisted living
Published on 11/21/2024 at 10:03, 39 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 42 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 42 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 7 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 17 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 12 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 37 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 40 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 42 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 42 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 44 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 22 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 57 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 57 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
